BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12142371)

  • 1. Plasma nucleic acids in the diagnosis and management of malignant disease.
    Johnson PJ; Lo YM
    Clin Chem; 2002 Aug; 48(8):1186-93. PubMed ID: 12142371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating nucleic acids as a tumor marker.
    Chan KC; Lo YM
    Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating nucleic acids (CNAs) and cancer--a survey.
    Fleischhacker M; Schmidt B
    Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
    Bremnes RM; Sirera R; Camps C
    Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
    Anker P; Mulcahy H; Stroun M
    Int J Cancer; 2003 Jan; 103(2):149-52. PubMed ID: 12455027
    [No Abstract]   [Full Text] [Related]  

  • 6. New markers for cancer detection.
    Wong IH; Lo YM
    Curr Oncol Rep; 2002 Nov; 4(6):471-7. PubMed ID: 12354358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias.
    Goebel G; Zitt M; Zitt M; Müller HM
    Dis Markers; 2005; 21(3):105-20. PubMed ID: 16276004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring.
    Lo YM
    Ann N Y Acad Sci; 2001 Sep; 945():68-72. PubMed ID: 11708496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
    Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
    Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
    Taback B; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating DNA in plasma or serum.
    Anker P; Stroun M
    Medicina (B Aires); 2000; 60(5 Pt 2):699-702. PubMed ID: 11188885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating nucleic acids as a potential source for cancer biomarkers.
    Vlassov VV; Laktionov PP; Rykova EY
    Curr Mol Med; 2010 Mar; 10(2):142-65. PubMed ID: 20196731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.
    Holdenrieder S
    Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.
    De Maio G; Rengucci C; Zoli W; Calistri D
    World J Gastroenterol; 2014 Jan; 20(4):957-67. PubMed ID: 24574768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating nucleic acids in plasma and serum: an overview.
    Lo YM
    Ann N Y Acad Sci; 2001 Sep; 945():1-7. PubMed ID: 11708462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.
    Tian F; Yip SP; Kwong DL; Lin Z; Yang Z; Wu VW
    Cancer Epidemiol; 2013 Oct; 37(5):708-13. PubMed ID: 23790641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.
    Gahan PB
    Infect Disord Drug Targets; 2008 Jun; 8(2):100-8. PubMed ID: 18537705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy.
    Silva JM; Garcia JM; Dominguez G; Silva J; Miralles C; Cantos B; Coca S; Provencio M; España P; Bonilla F
    Ann Surg Oncol; 2002; 9(1):71-6. PubMed ID: 11829433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.